Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio

(Brussels:NYXH),(NasdaqGM:NYXH), INSIDE INFORMATIONREGULATED INFORMATION Correction and Replacement Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio Financings are comprised of equity investments, including from Cochlear, Resmed and Nyxoah's Chairman and Management, and a convertible bond. This press release replaces the press release issued on November 13, 2025, at […]

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio GlobeNewswire November 14, 2025 INSIDE INFORMATIONREGULATED INFORMATION Correction and Replacement Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio Financings are comprised of equity investments, including from Cochlear, Resmed and Nyxoah's Chairman

Weyerhaeuser Company Declares Dividend on Common Shares

Weyerhaeuser Company(NYSE: WY) today announced that its board of directors declared a quarterly base cash dividend of $0.21 per share on the common stock of the company, payable in cash on December 12, 2025, to holders of record of such common stock as of the close of business on November 28, 2025. https://mma.prnewswire.com/media/321594/WEYERHAEUSER_LOGO.jpg Under Weyerhaeuser's

Smith-Midland Reports Third Quarter 2025 Financial Results

Product Sales Increased 11 Percent and Record Nine-Month Net Income MIDLAND, VA / ACCESS Newswire / November 13, 2025 / Smith-Midland Corporation (NASDAQ:SMID), a provider of innovative, high-quality proprietary and patented precast concrete products and systems, today announced its third quarter results for the period ended September 30, 2025. Third Quarter 2025 Summary (compared to

NX Investors Have Opportunity to Lead Quanex Building Products Corporation Securities Fraud Lawsuit

https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Quanex Building Products Corporation (NYSE: NX) between December 12, 2024 and September 5, 2025, both dates inclusive (the “Class Period”), of the important November 18, 2025 lead plaintiff deadline. So what: If you purchased Quanexsecurities during the Class Period

Condor Announces 2025 Third Quarter Results

(TSX:CDR), CALGARY, Alberta, Nov. 13, 2025 (GLOBE NEWSWIRE) — Condor Energies Inc. (“Condor” or the “Company”) (TSX:CDR), a Canadian based, internationally focused energy transition company focused on Central Asia is pleased to announce the release of its unaudited interim condensed consolidated financial statements for the three and nine months ended September 30, 2025 (the “Financial

Condor Announces 2025 Third Quarter Results

Condor Announces 2025 Third Quarter Results GlobeNewswire November 14, 2025 CALGARY, Alberta, Nov. 13, 2025 (GLOBE NEWSWIRE) — Condor Energies Inc. (“Condor” or the “Company”) (TSX:CDR), a Canadian based, internationally focused energy transition company focused on Central Asia is pleased to announce the release of its unaudited interim condensed consolidated financial statements for the three

Class Action Lawsuit Filed: Inspire Medical Systems, Inc. (INSP) – Join by January 5, 2026 – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / November 13, 2025 / If you suffered a loss on your Inspire Medical Systems, Inc. (NYSE:INSP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inspire-medical-systems-inc-lawsuit-submission-form?prid=177281&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

Class Action Lawsuit Filed Against Cytokinetics, Incorporated (CYTK) – Recover Losses – Contact Levi & Korsinsky Before November 17, 2025

NEW YORK, NY / ACCESS Newswire / November 13, 2025 / If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ:CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=177280&wire=1&utm_campaign=9 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

WPP Investors Have Opportunity to Lead WPP plc Securities Fraud Lawsuit

https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADS” or “ADSs”) of WPP plc (NYSE: WPP) between February 27, 2025 and July 8, 2025, both dates inclusive (the “Class Period”), of the important December 8, 2025 lead plaintiff deadline. So what: If you purchased WPP plc

Scroll to Top